Irreversible electroporation for locally advanced pancreatic cancer in an HIV-positive patient [0.03%]
HIV阳性患者的局部晚期胰腺癌不可逆电穿孔疗法
Yan Zheng,Chong-Kai Ruan,Chong Peng et al.
Yan Zheng et al.
Oriana Barrios,David Merino,Kristel Mils et al.
Oriana Barrios et al.
Bo Zhang,Yi-Fan Jiang,Jia-Jie Yu
Bo Zhang
Timing of endoscopic retrograde cholangiopancreatography in acute cholangitis: A cohort study in Colombia [0.03%]
急性胆管炎ERCP内镜逆行胰胆管造影时机的队列研究（哥伦比亚）
Juan Pablo García-Marmolejo,Miguel Aguilar-Shotborgh,Cándida Diaz-Brochero et al.
Juan Pablo García-Marmolejo et al.
Machine perfusion improves outcomes of liver recipients via non-immunomodulatory effects [0.03%]
机器灌注通过非免疫调节作用改善肝脏移植受者的结局
Giulia Cirillo,Serena Babboni,Daniele Pezzati et al.
Giulia Cirillo et al.
Liver transplantation (LT) is limited by organ shortage, increasingly relying on extended criteria donors (ECD) and donation after circulatory death (DCD) grafts, which are particularly vulnerable to ischemia-reperfusion injury (IRI). Beyon...
Bile acids as gatekeepers: Orchestrating gut-liver axis for metabolic and immune balance [0.03%]
胆酸作为守护者：协调肠肝轴以维持代谢和免疫平衡
Qiang Chen,Xin Liu,Zi-Hao Jiang
Qiang Chen
Bile acids (BAs) represent the terminal products of cholesterol catabolism and are integral to a wide range of physiological processes. The maintenance of BAs homeostasis is essential for human health, with disruptions being implicated in v...
Real-world impact of the management of advanced perihilar and extrahepatic cholangiocarcinoma on prognosis [0.03%]
晚期肝门和额外 hepatobiliary癌症的管理对预后的真实世界影响
Marie Decraecker,Valérie Aurillac,Jean-Frédéric Blanc
Marie Decraecker
Background: Cholangiocarcinomas (CCAs), including perihilar CCA (pCCA) and extrahepatic CCA (eCCA), are aggressive cancers with poor prognosis. Most patients are diagnosed at advanced stages. Jaundice and infection, commo...
From futility to promise: Preemptive veno-arterial extracorporeal membrane oxygenation benefits high-risk liver transplant patients [0.03%]
从无能为力到看到希望：预置式静脉动脉体外膜氧合可使肝移植高危患者受益
Nan Ye,Chuang-Hui Lu,Kai Wun Chang et al.
Nan Ye et al.
Yttrium-90 downstages giant hepatocellular carcinoma to resectable size [0.03%]
90钇下将巨块型原发性肝癌转化为可切除肿瘤的治疗效果
Qin-Liang Fang,Yu Xiong,Ying-Lang Zeng et al.
Qin-Liang Fang et al.
Cost-effectiveness of ivosidenib in patients with previously treated isocitrate dehydrogenase 1 (IDH1)-mutant cholangiocarcinoma: An Italian perspective [0.03%]
从意大利视角看艾伏尼布治疗既往接受过治疗的异柠檬酸脱氢酶1突变型胆管癌的成本效益分析
Jacopo Giuliani,Emilia Durante,Marco Muraro et al.
Jacopo Giuliani et al.